Literature DB >> 7701249

Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease.

A Ikehata1, N Hiwatashi, Y Kinouchi, H Yamazaki, K Ito, T Toyota.   

Abstract

BACKGROUND: omega-Oxidation is regarded as the major pathway for leukotriene B4 (LTB4) metabolism. Very little is known about it in colonic mucosa with inflammatory bowel disease (IBD).
METHODS: We investigated the metabolic ratio of omega-oxidation to LTB4 biosynthesis in colonic mucosa from patients with IBD and control subjects. After incubation of colonic mucosa with 14C-arachidonic acid and ionophore A23187, we separated LTB4 and its omega-oxidative metabolites by high-performance liquid chromatography.
RESULTS: The rate of LTB4 omega-oxidation was comparable to the rate of its biosynthesis. The metabolic ratio was significantly decreased in inflamed mucosa with ulcerative colitis.
CONCLUSIONS: LTB4 omega-hydroxylase activity is an important factor in regulating LTB4 level in colonic mucosa, and the increased LTB4 level in inflamed mucosa with IBD, especially ulcerative colitis, is caused by decreased LTB4 omega-hydroxylase activity and increased 5-lipoxygenase activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7701249     DOI: 10.3109/00365529509093234

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

Review 1.  The enzymology and pharmacology of 5-lipoxygenase and 5-lipoxygenase activating protein.

Authors:  R L Bell; R R Harris
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 2.  Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data.

Authors:  Mona Abdel-Tawab; Oliver Werz; Manfred Schubert-Zsilavecz
Journal:  Clin Pharmacokinet       Date:  2011-06       Impact factor: 6.447

Review 3.  Eicosanoids in the gastrointestinal tract.

Authors:  John L Wallace
Journal:  Br J Pharmacol       Date:  2018-04-16       Impact factor: 8.739

4.  Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study.

Authors:  Ashwin N Ananthakrishnan; Hamed Khalili; Mingyang Song; Leslie M Higuchi; Paul Lochhead; James M Richter; Andrew T Chan
Journal:  Inflamm Bowel Dis       Date:  2017-11       Impact factor: 5.325

5.  Genes involved in the metabolism of poly-unsaturated fatty-acids (PUFA) and risk for Crohn's disease in children & young adults.

Authors:  Irina Costea; David R Mack; David Israel; Kenneth Morgan; Alfreda Krupoves; Ernest Seidman; Colette Deslandres; Philippe Lambrette; Guy Grimard; Emile Levy; Devendra K Amre
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

6.  Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology.

Authors:  Mojgan Masoodi; Daniel S Pearl; Michael Eiden; Janis K Shute; James F Brown; Philip C Calder; Timothy M Trebble
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

7.  Involvement of Proinflammatory Arachidonic Acid (ARA) Derivatives in Crohn's Disease (CD) and Ulcerative Colitis (UC).

Authors:  Justyna Kikut; Małgorzata Mokrzycka; Arleta Drozd; Urszula Grzybowska-Chlebowczyk; Maciej Ziętek; Małgorzata Szczuko
Journal:  J Clin Med       Date:  2022-03-27       Impact factor: 4.241

8.  CYP4F18-Deficient Neutrophils Exhibit Increased Chemotaxis to Complement Component C5a.

Authors:  Rachel Vaivoda; Christine Vaine; Cassandra Boerstler; Kristy Galloway; Peter Christmas
Journal:  J Immunol Res       Date:  2015-11-03       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.